Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,635 | $4.34 | $7,096 | 146,021 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
19,855 | $4.34 | $86,171 | 1,244,802 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,402 | $4.34 | $71,185 | 1,116,590 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
139,791 | $3.7 | $517,227 | 1,264,657 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
136,421 | $3.7 | $504,758 | 1,132,992 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
12,127 | $3.7 | $44,870 | 147,656 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
703 | $3.84 | $2,700 | 159,783 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
5,107 | $3.84 | $19,611 | 1,269,413 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
8,509 | $3.84 | $32,675 | 1,404,448 (Direct) |
View |
| 2022-04-22 Purchase |
2022-04-26 06:48 am |
Roivant Sciences Ltd. | ROIV | Dexcel Pharma Technologies Ltd. Dexxon Holdings Ltd. Oren Dan 10% Owner |
40,285 | $3.8464 | $154,954 | 98,849,443 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
19,336 | $4.84 | $93,586 | 1,274,520 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,486 | $4.84 | $12,032 | 160,486 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
33,686 | $4.84 | $163,040 | 1,412,957 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 6:31 pm |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
80,045 | $5.06 | $405,028 | 1,308,948 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 6:29 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
35,386 | $5.06 | $179,053 | 1,471,897 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 6:27 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
7,281 | $5.06 | $36,842 | 165,049 (Direct) |
View |
| 2022-03-18 Sale |
2022-03-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,153 | $5.13 | $11,045 | 172,330 (Direct) |
View |
| 2022-03-18 Sale |
2022-03-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
82,006 | $5.13 | $420,691 | 1,507,283 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 9:45 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
3,091 | $5.52 | $17,062 | 174,483 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 9:45 pm |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
92,324 | $5.52 | $509,628 | 1,589,289 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-20 Option Award |
2022-04-22 7:31 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh See Remarks |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:29 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:27 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:26 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:25 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
16,523,184 | $0 | 16,523,184 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Venker Eric President & COO |
15,092 | $4.74 | 1,274,520 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,077 | $4.74 | 160,486 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
25,254 | $4.74 | 1,412,957 (Direct) |
View |
| 2021-10-20 Option Award |
2021-10-22 4:07 pm |
N/A 2031-10-19 |
Roivant Sciences Ltd. | ROIV | Pulik Richard CHIEF FINANCIAL OFFICER |
313,419 | $0 | 313,419 (Direct) |
View |
| 2021-10-18 Conversion |
2021-10-20 5:14 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Roivant Sciences Ltd. 10% Owner |
23,997,922 | $0 | 38,847,462 (Direct) |
View |
Ownership |
2021-10-01 6:42 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek Director |
0 | $0 | 109,790,444 (Direct) |
View |
Ownership |
2021-10-01 6:32 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | VIKING GLOBAL PERFORMANCE LLC Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Equities Master Ltd. Viking Global Equities II LP Viking Long Fund Master Ltd. Viking Long Fund GP LLC 10% Owner |
0 | $0 | 88,238,700 (Indirect) |
View |
Ownership |
2021-10-01 6:27 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | VIKING GLOBAL INVESTORS LP Ott David C. HALVORSEN OLE ANDREAS Shabet Rose Sharon Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC 10% Owner |
0 | $0 | 88,238,700 (Indirect) |
View |
Ownership |
2021-10-01 5:50 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gline Matthew CEO |
0 | $0 | 12,830,174 (Direct) |
View |
Ownership |
2021-10-01 5:49 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Pulik Richard CFO |
0 | $0 | 220,015 (Direct) |
View |
Ownership |
2021-10-01 5:49 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director |
0 | $0 | 89,625,117 (Indirect) |
View |
Ownership |
2021-10-01 5:47 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
0 | $0 | 984,440 (Direct) |
View |
Ownership |
2021-10-01 5:47 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director |
0 | $0 | 129,393,817 (Indirect) |
View |
Ownership |
2021-10-01 5:43 pm |
N/A 2026-10-19 |
Roivant Sciences Ltd. | ROIV | Machado Patrick Director |
0 | $0 | 609,095 (Direct) |
View |
Ownership |
2021-10-01 5:41 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Zimmer Benjamin President, Roivant Health |
0 | $0 | 4,768,874 (Direct) |
View |